4//SEC Filing
Cotroneo Pat 4
Accession 0001209191-20-049618
CIK 0000921299other
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 4:30 PM ET
Size
16.4 KB
Accession
0001209191-20-049618
Insider Transaction Report
Form 4
FIBROGEN INCFGEN
Controneo Pat
VP, Finance and CFO
Transactions
- Exercise/Conversion
Common Stock
2020-09-03$29.66/sh+637$18,893→ 278,947 total - Exercise/Conversion
Common Stock
2020-09-03$25.40/sh+8,671$220,243→ 293,314 total - Sale
Common Stock
2020-09-03$50.91/sh−15,004$763,854→ 278,310 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-09-03−637→ 4,618 totalExercise: $29.66Exp: 2025-03-04→ Common Stock (637 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2020-09-03−8,671→ 41,579 totalExercise: $25.40Exp: 2027-03-08→ Common Stock (8,671 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2020-09-03−5,696→ 0 totalExercise: $19.39Exp: 2026-02-22→ Common Stock (5,696 underlying) - Exercise/Conversion
Common Stock
2020-09-03$19.39/sh+5,696$110,445→ 284,643 total
Footnotes (4)
- [F1]Shares sold pursuant to a 10b5-1 plan.
- [F2]The shares were sold at prices ranging from $50.89 to $51.00. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Fully vested.
- [F4]Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in equal amounts quarterly thereafter for the following three years.
Documents
Issuer
FIBROGEN INC
CIK 0000921299
Entity typeother
Related Parties
1- filerCIK 0001621334
Filing Metadata
- Form type
- 4
- Filed
- Sep 3, 8:00 PM ET
- Accepted
- Sep 4, 4:30 PM ET
- Size
- 16.4 KB